Hypera (HYPMY) Short Interest Ratio & Short Volume → **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad) Free HYPMY Stock Alerts $5.85 +0.06 (+1.04%) (As of 05/17/2024 08:55 PM ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Hypera Short Interest DataCurrent Short Interest1,900 sharesPrevious Short Interest17,400 sharesChange Vs. Previous Month-89.08%Dollar Volume Sold Short$10,934.50Short Interest Ratio0.1 Days to CoverLast Record DateApril 15, 2024Today's Trading Volume15,900 sharesAverage Trading Volume30,693 sharesToday's Volume Vs. Average52% Short Selling Hypera ? Sign up to receive the latest short interest report for Hypera and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHYPMY Short Interest Over TimeHYPMY Days to Cover Over TimeHYPMY Percentage of Float Shorted Over Time Ad Huge Alerts**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report Hypera Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,900 shares $10,934.50 -89.1%N/A0.1 $5.76 3/31/202417,400 shares $116,493.00 No ChangeN/A1.2 $6.70 3/15/202417,400 shares $120,930.00 +10.8%N/A1.7 $6.95 2/29/202415,700 shares $111,823.25 +8.3%N/A1.8 $7.12 2/15/202414,500 shares $93,670.00 +5.8%N/A0.3 $6.46 1/15/20247,700 shares $57,596.00 +327.8%N/A0.3 $7.48 Get the Latest News and Ratings for HYPMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hypera and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,800 shares $12,888.00 -48.6%N/A0.1 $7.16 12/15/20233,500 shares $25,392.50 -81.2%N/A0.1 $7.26 11/30/202318,600 shares $129,084.00 +44.2%N/A0.6 $6.94 11/15/202312,900 shares $88,365.00 -14.6%N/A0.3 $6.85 10/31/202315,100 shares $92,412.00 No ChangeN/A0.1 $6.12 9/15/20233,300 shares $25,311.00 -43.1%N/A1 $7.67 8/31/20235,800 shares $44,950.00 +5,700.0%N/A0.6 $7.75 8/15/2023100 shares $848.00 -90.0%N/A0 $8.48 7/31/20231,000 shares $9,155.00 No ChangeN/A0.2 $9.16 6/30/20231,000 shares $9,615.00 +150.0%N/A0.1 $9.62 6/15/2023400 shares $3,788.00 -75.0%N/A0 $9.47 5/31/20231,600 shares $12,960.00 +300.0%N/A0.1 $8.10 5/15/2023400 shares $3,084.00 No ChangeN/A0.1 $7.71 4/30/2023400 shares $2,996.00 +100.0%N/A0.1 $7.49 4/15/2023200 shares $1,495.16 No ChangeN/A0 $7.48 3/31/2023200 shares $1,472.00 No ChangeN/A0 $7.36 2/28/2023900 shares $6,885.00 +800.0%N/A0 $7.65 2/15/2023100 shares $888.87 No ChangeN/A0 $8.89 12/30/2022900 shares $7,560.00 -35.7%N/A0 $8.40 12/15/20221,400 shares $11,060.00 No ChangeN/A0.1 $7.90 11/15/20222,300 shares $21,125.50 No ChangeN/A0.1 $9.19 10/15/2022200 shares $1,734.00 No ChangeN/A0 $8.67 8/15/2022300 shares $2,427.00 No ChangeN/A0 $8.09 7/15/20223,600 shares $26,496.00 +350.0%N/A0.1 $7.36 6/30/2022800 shares $5,630.40 -75.0%N/A0.1 $7.04 6/15/20223,200 shares $24,390.40 -28.9%N/A0.3 $7.62 5/31/20224,500 shares $36,225.00 -15.1%N/A0.1 $8.05 5/15/20225,300 shares $39,074.25 -35.4%N/A0.2 $7.37 4/30/20228,200 shares $65,190.00 -62.4%N/A0.5 $7.95 4/15/202221,800 shares $179,065.20 +198.6%N/A1.8 $8.21 3/31/20227,300 shares $58,867.20 -50.0%N/A0.1 $8.06 3/15/202214,600 shares $93,994.80 +55.3%N/A0.9 $6.44 2/28/20229,400 shares $58,430.40 -59.1%N/A0.5 $6.22 2/15/202223,000 shares $140,990.00 +303.5%N/A0.4 $6.13**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report 1/31/20225,700 shares $33,516.00 -45.7%N/A0.2 $5.88 1/15/202210,500 shares $54,600.00 No ChangeN/A0.3 $5.20 12/15/20212,600 shares $13,286.00 +2,500.0%N/A0.1 $5.11 11/30/2021100 shares $478.00 -92.9%N/A0 $4.78 11/15/20211,400 shares $7,350.00 -74.6%N/A0.1 $5.25 10/29/20215,500 shares $27,115.00 -57.4%N/A0.2 $4.93 10/15/202112,900 shares $70,692.00 +40.2%N/A0.8 $5.48 9/30/20219,200 shares $54,648.00 -69.2%N/A0.5 $5.94 9/15/202129,900 shares $194,051.00 +967.9%N/A1.1 $6.49 8/31/20212,800 shares $19,068.00 -46.2%N/A0.1 $6.81 8/13/20215,200 shares $35,984.00 No ChangeN/A0.3 $6.92 7/30/20215,200 shares $35,880.00 +100.0%N/A0.3 $6.90 7/15/20212,600 shares $17,719.00 -76.8%N/A0.2 $6.82 6/30/202111,200 shares $76,787.20 +187.2%N/A0.3 $6.86 6/15/20213,900 shares $27,274.65 -51.3%N/A0.2 $6.99 5/28/20217,300 shares $50,443.00 +15.9%N/A1 $6.91 5/14/20216,300 shares $39,942.00 +117.2%N/A0.7 $6.34 4/30/20212,900 shares $19,053.00 +26.1%N/A0.2 $6.57 4/15/20212,300 shares $13,961.00 No ChangeN/A0.2 $6.07 3/31/20212,300 shares $12,903.00 -70.1%N/A0.1 $5.61 3/15/20217,700 shares $43,304.80 +87.8%N/A0.3 $5.62 2/26/20214,100 shares $25,510.20 -64.7%N/A0.2 $6.22 2/12/202111,600 shares $72,732.00 -65.7%N/A0.4 $6.27 1/29/202133,800 shares $219,024.00 +297.7%N/A1.2 $6.48 1/15/20215,100 shares $34,782.00 -48.5%N/A0.2 $6.82 12/31/20206,200 shares $42,036.00 +21.6%N/A0.1 $6.78 12/15/20205,100 shares $32,130.00 -48.5%N/A0.2 $6.30 11/30/20209,900 shares $57,915.00 +125.0%N/A0.3 $5.85 11/15/20204,400 shares $24,288.00 +1,366.7%N/A0.1 $5.52 10/30/2020300 shares $1,491.00 +200.0%N/A0 $4.97 10/15/2020100 shares $548.00 -66.7%N/A0 $5.48 9/30/2020300 shares $1,579.50 -78.6%N/A0 $5.27 9/15/20201,400 shares $8,386.00 -79.1%N/A0 $5.99 8/31/20206,700 shares $38,994.00 +63.4%N/A0 $5.82 8/14/20204,100 shares $24,898.07 +272.7%N/A0 $6.07 7/31/20201,100 shares $7,544.02 -26.7%N/A0 $6.86 7/15/20201,500 shares $8,797.50 +50.0%N/A0 $5.87 6/30/20201,000 shares $6,010.00 -37.5%N/A0 $6.01 6/15/20201,600 shares $9,968.00 -59.0%N/A0.1 $6.23 5/29/20203,900 shares $22,776.00 -77.2%N/A0.1 $5.84 5/15/202017,100 shares $80,370.00 No ChangeN/A0.2 $4.70 3/31/20201,500 shares $7,608.00 +275.0%N/A0 $5.07 3/13/2020400 shares $2,601.60 +100.0%N/A0 $6.50 2/28/2020200 shares $1,510.00 -97.6%N/A0 $7.55 2/14/20208,200 shares $64,862.00 +446.7%N/A0.5 $7.91 1/31/20201,500 shares $12,348.00 -89.0%N/A0.1 $8.23 1/15/202013,600 shares $121,040.00 +1,411.1%N/A0.5 $8.90 12/31/2019900 shares $7,524.00 +800.0%N/A0 $8.36 HYPMY Short Interest - Frequently Asked Questions What is Hypera's current short interest? Short interest is the volume of Hypera shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 1,900 shares of HYPMY short. Learn More on Hypera's current short interest. Is Hypera's short interest increasing or decreasing? Hypera saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 1,900 shares, a drop of 89.1% from the previous total of 17,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Hypera's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Hypera: Grifols, S.A. (2.61%), IMV Inc. (1.31%), LAVA Therapeutics (0.86%), Mainz Biomed (2.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Hypera stock? Short selling HYPMY is an investing strategy that aims to generate trading profit from Hypera as its price is falling. HYPMY shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hypera? A short squeeze for Hypera occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HYPMY, which in turn drives the price of the stock up even further. How often is Hypera's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HYPMY, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Abliva AB (publ) Short Squeeze Affymax Short Squeeze American Bio Medica Short Squeeze Anthera Pharmaceuticals Short Squeeze Bayer Aktiengesellschaft Short Squeeze EOM Pharmaceuticals Short Squeeze EPIRUS Biopharmaceuticals Short Squeeze Genmab A/S Short Squeeze GlobeImmune Short Squeeze Grifols Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HYPMY) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldShocking: One AI startup's revenue could surge 4,735%Manward PressDoes this make you sick?Allegiance GoldCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBiden Nomination CANCELED?The Freeport SocietyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star